FRONTIER CAPITAL MANAGEMENT CO LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,788,655
+1.5%
757,613
+16.6%
0.17%
+16.8%
Q2 2023$15,560,555
+54.8%
649,710
+21.7%
0.15%
+43.3%
Q1 2023$10,050,915
+74.9%
534,055
+48.0%
0.10%
+65.1%
Q4 2022$5,745,162
-27.5%
360,877
-25.5%
0.06%
-32.3%
Q3 2022$7,927,000
-0.7%
484,563
-14.4%
0.09%
+1.1%
Q2 2022$7,979,000
-62.5%
566,323
-35.6%
0.09%
-52.3%
Q1 2022$21,289,000
-13.7%
878,990
-16.8%
0.19%
-1.0%
Q4 2021$24,664,000
+281.1%
1,056,713
+171.3%
0.20%
+282.4%
Q3 2021$6,471,000
-74.7%
389,569
-62.8%
0.05%
-72.7%
Q2 2021$25,545,000
+114.6%
1,047,347
+127.0%
0.19%
+107.8%
Q1 2021$11,904,000
-76.8%
461,377
-51.9%
0.09%
-76.3%
Q4 2020$51,252,000
+25.0%
958,692
-3.6%
0.38%
+5.9%
Q3 2020$41,004,000
-28.7%
994,039
-16.2%
0.36%
-29.7%
Q2 2020$57,509,000
+0.4%
1,186,484
-12.5%
0.51%
-20.8%
Q1 2020$57,268,000
+780.5%
1,355,455
+368.3%
0.64%
+1268.1%
Q1 2018$6,504,000
+146.2%
289,443
+229.9%
0.05%
+147.4%
Q4 2017$2,642,000
-82.7%
87,734
-78.4%
0.02%
-82.7%
Q3 2017$15,314,000
-18.3%
406,521
-39.5%
0.11%
-19.7%
Q2 2017$18,734,000
-14.3%
671,709
+5.7%
0.14%
-14.9%
Q1 2017$21,855,000
+102.2%
635,688
+69.6%
0.16%
+94.0%
Q4 2016$10,811,000
-46.4%
374,873
-40.8%
0.08%
-48.4%
Q3 2016$20,158,000
+129.0%
633,690
+133.6%
0.16%
+123.6%
Q2 2016$8,804,000
+11.6%
271,231
-3.9%
0.07%
+14.3%
Q1 2016$7,890,000
-35.9%
282,199
-18.3%
0.06%
-38.2%
Q4 2015$12,313,000345,3840.10%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders